{
    "eid": "2-s2.0-85107902923",
    "title": "Intralymphatic immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis",
    "cover-date": "2021-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Otorhinolaryngology",
            "@code": "2733",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Allergic rhinitis",
        "Allergy",
        "IgE",
        "Intralymphatic immunotherapy",
        "Pollinosis"
    ],
    "authors": [
        "Minh P. Hoang",
        "Kachorn Seresirikachorn",
        "Wirach Chitsuthipakorn",
        "Kornkiat Snidvongs"
    ],
    "citedby-count": 14,
    "ref-count": 35,
    "ref-list": [
        "Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence",
        "International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis",
        "Allergen Immunotherapy: History and Future Developments",
        "Mechanisms of allergen-specific immunotherapy: Diverse mechanisms of immune tolerance to allergens",
        "Novel administration routes for allergen-specific immunotherapy: a review of intralymphatic and epicutaneous allergen-specific immunotherapy",
        "Antigen localisation regulates immune responses in a dose-and time-dependent fashion: a geographical view of immune reactivity",
        "Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens",
        "Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial",
        "Clinical efficacy and safety of cervical intralymphatic immunotherapy for house dust mite allergic rhinitis: A pilot study",
        "Intralymphatic immunotherapy",
        "Intralymphatic Immunotherapy: Update and Unmet Needs",
        "Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis",
        "Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement",
        "Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)",
        "Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper",
        "The Cochrane Collaboration's tool for assessing risk of bias in randomised trials",
        "Methodological index for non-randomized studies (minors): development and validation of a new instrument",
        "Review Manager (RevMan) 5.4 ed, Copenhagen: The Nordic Cochrane Centre",
        "Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections",
        "Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?",
        "Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial",
        "Three-injection intralymphatic immunotherapy in adolescents and young adults with grass pollen rhinoconjunctivitis",
        "A Pilot Study of Intralymphatic Immunotherapy for House Dust Mite, Cat, and Dog Allergies",
        "Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass: A randomized, double-blind, placebo-controlled trial",
        "Intralymphatic immunotherapy in pollen-allergic young adults with rhinoconjunctivitis and mild asthma: A randomized trial",
        "Intralymphatic immunotherapy improves grass pollen allergic rhinoconjunctivitis: A 3-year randomized placebo-controlled trial",
        "Sustained effects of intralymphatic pollen-specific immunotherapy on Japanese cedar pollinosis",
        "Intralymphatic immunotherapy for mountain cedar pollinosis: A randomized, double-blind, placebo-controlled trial",
        "A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy",
        "IgG4 but no IgG1 antibody production after intralymphatic immunotherapy with recombinant MAT-Feld1 in human",
        "Clinical practice guideline: allergic rhinitis executive summary",
        "Immunotherapy of allergic disease",
        "Solving the Problem of Nonadherence to Immunotherapy",
        "Intralymphatic injections as a new administration route for allergen-specific immunotherapy",
        "Intralymphatic immunotherapy: time interval between injections is essential"
    ],
    "affiliation": [
        {
            "affiliation-city": "Hue",
            "@id": "60112689",
            "affilname": "University Medicine and Pharmacy, Hue University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60112689",
            "affiliation-country": "Viet Nam"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60023366",
            "affilname": "Rangsit University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023366",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60005255",
            "affilname": "Rajavithi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005255",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}